A day after Bharat Biotech slammed Serum Institute of India's CEO Adar Poonawalla for his 'water' comment about some COVID-19 vaccines, both the vaccine makers on Tuesday jointly pledged for a......
Bharat Biotech on Thursday said it plans to produce additional 200 million (20 crore) doses of COVID-19 vaccine 'Covaxin' at its subsidiary's Gujarat-based facility, taking the overall production......
This will be an upfront payment for the vaccine doses that these two companies will supply to the government.Sohini Das and Dilasha Seth report. Photograph: PTI Photo. Vaccine manufacturers......
Sources indicated that as there were no fresh orders from the Government of India, their supply commitments have ended as of March 31, reports Sohini Das. IMAGE: Vials of Covishield vaccine.......
The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to manufacture COVID-19 vaccine Covovax for restricted use in emergency situations at its......
Stocks of Oxford COVID-19 vaccine, Covishield, are likely to start moving out of Serum Institute of India's facility here on early Tuesday morning, days ahead of the nationwide inoculation drive,......